Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.

Pollreisz A, Hudson BI, Chang JS, Qu W, Cheng B, Papapanou PN, Schmidt AM, Lalla E.

Atherosclerosis. 2010 Oct;212(2):451-6. doi: 10.1016/j.atherosclerosis.2010.07.011. Epub 2010 Jul 21.

2.

Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.

Liu M, Yu Y, Jiang H, Zhang L, Zhang PP, Yu P, Jia JG, Chen RZ, Zou YZ, Ge JB.

Acta Pharmacol Sin. 2013 Jun;34(6):830-6. doi: 10.1038/aps.2013.8. Epub 2013 Apr 8.

3.

Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.

Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, Schmidt AM, Lalla E.

Atherosclerosis. 2007 Feb;190(2):271-81. Epub 2006 Apr 18.

PMID:
16620832
4.

Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide.

Chang PC, Chien LY, Chong LY, Kuo YP, Hsiao JK.

J Periodontal Res. 2013 Apr;48(2):184-93. doi: 10.1111/j.1600-0765.2012.01519.x. Epub 2012 Aug 26.

PMID:
22924807
5.
6.

Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells.

Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd, Genco CA.

Cell Microbiol. 2006 May;8(5):738-57.

PMID:
16611224
7.

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.

Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.

Cardiovasc Res. 2009 May 1;82(2):371-81. doi: 10.1093/cvr/cvp036. Epub 2009 Jan 28.

PMID:
19176597
8.

A murine model of accelerated periodontal disease in diabetes.

Lalla E, Lamster IB, Feit M, Huang L, Schmidt AM.

J Periodontal Res. 1998 Oct;33(7):387-99.

PMID:
9842504
9.

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, Kislinger T, Lu Y, Stern DM, Schmidt AM.

J Clin Invest. 2000 Apr;105(8):1117-24.

10.

The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.

Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Salvi L, Pesce CM, Relucenti M, Familiari G, Taurino M, Pugliese G.

Cardiovasc Res. 2013 Dec 1;100(3):472-80. doi: 10.1093/cvr/cvt206. Epub 2013 Aug 23.

PMID:
23975852
11.

Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells.

Roth GA, Moser B, Huang SJ, Brandt JS, Huang Y, Papapanou PN, Schmidt AM, Lalla E.

J Thromb Haemost. 2006 Oct;4(10):2256-61.

12.

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.

Wendt T, Harja E, Bucciarelli L, Qu W, Lu Y, Rong LL, Jenkins DG, Stein G, Schmidt AM, Yan SF.

Atherosclerosis. 2006 Mar;185(1):70-7. Epub 2005 Aug 1.

PMID:
16076470
13.

Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.

Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J.

Clin J Am Soc Nephrol. 2008 May;3(3):691-8. doi: 10.2215/CJN.04291007. Epub 2008 Feb 6.

14.

Shear stress modulates RAGE-mediated inflammation in a model of diabetes-induced metabolic stress.

DeVerse JS, Bailey KA, Jackson KN, Passerini AG.

Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2498-508. doi: 10.1152/ajpheart.00869.2011. Epub 2012 Mar 30.

15.

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.

Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB.

Atherosclerosis. 2008 Dec;201(2):274-80. doi: 10.1016/j.atherosclerosis.2008.01.015. Epub 2008 Feb 16.

PMID:
18371970
16.

Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice.

Ramsgaard L, Englert JM, Manni ML, Milutinovic PS, Gefter J, Tobolewski J, Crum L, Coudriet GM, Piganelli J, Zamora R, Vodovotz Y, Enghild JJ, Oury TD.

PLoS One. 2011;6(5):e20132. doi: 10.1371/journal.pone.0020132. Epub 2011 May 23.

17.

Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis.

Ha CH, Kim S, Chung J, An SH, Park S, Choi D, Kwon K.

Int J Mol Med. 2013 Aug;32(2):373-80. doi: 10.3892/ijmm.2013.1393. Epub 2013 May 27.

PMID:
23708564
18.

C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.

Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, Verma S.

Hypertension. 2006 Sep;48(3):504-11. Epub 2006 Jul 17.

PMID:
16847147
19.

Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.

Chou HH, Yumoto H, Davey M, Takahashi Y, Miyamoto T, Gibson FC 3rd, Genco CA.

Infect Immun. 2005 Sep;73(9):5367-78.

20.

Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.

Chen J, Song M, Yu S, Gao P, Yu Y, Wang H, Huang L.

Mol Cell Biochem. 2010 Feb;335(1-2):137-46. doi: 10.1007/s11010-009-0250-y. Epub 2009 Sep 15.

PMID:
19756958

Supplemental Content

Support Center